Careers
Contact Us
Log in
Facebook
Twitter
Linkedin
About Us
About Allergy Therapeutics
Our Vision
The Board
Executive Management Team
Management Team
History
Why Allergy Therapeutics?
What is MCT
®
?
Facilities & Process
R & D
Scientific Development
Clinical Development
Publications and Posters
Bencard Adjuvant Systems
Product Portfolio
Markets We Are In
Healthcare Professionals
Why Allergy Therapeutics?
Our Products
Pollinex
®
Trees
Pollinex
®
Grasses + Rye
Skin Prick Testing
Diagnostic Products
UK Specials Manufacturing Service
UK Specials Products
How to Order
Immunotherapy
Immunotherapy: From the beginning
Allergy Across The Globe
Allergy Vaccines
Investor Relations
Financial Performance
Share Price Information
Share Price Charting
Historic Share Price Download
Financial Indicators
Financial Calendar
Annual Reports
Shareholder Information
Registrar Details
Major Shareholders
General Meetings
Electronic Communications
Corporate Governance
The Board
Corporate Documents
Corporate Responsibility
Internal Control
Advisers
Analysts and Broker Forecasts
LSE Regulatory News
Email Alerts
AIM Rule 26
Financial Presentations
Careers
Positions Available
How to Apply
Contact Us
How to Find Us
Adverse Event Reporting
UK Sales Contacts
Corporate Details
Members
Your Account
Log Out
Log in
Home
Investor Relations
LSE Regulatory News
Print page
Save page
Share
LSE Regulatory News
Related Links
Financial Calendar
Advisers
AIM Rule 26
Print page
Save page
Share